ALEC Form 144 Filed for 5,717-Share Sale from RSU Vesting
Rhea-AI Filing Summary
Alector, Inc. (ALEC) Form 144 shows a proposed sale of 5,717 shares of common stock through Morgan Stanley Smith Barney on 09/02/2025 with an aggregate market value of $13,434.95. The shares were acquired by vesting of restricted stock units on 08/29/2025 totaling 11,257 units, with payment/settlement dated 08/29/2025. The filer previously sold 6,034 shares on 06/02/2025 for gross proceeds of $8,075.91. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Positive
- Disclosure compliance: Form 144 submitted with required sale and acquisition details
- Proceeds sourced from RSU vesting: shares to be sold were acquired through vesting on 08/29/2025
Negative
- Insider selling shares: Proposed sale of 5,717 shares (though small relative to 101,212,329 outstanding)
Insights
TL;DR: Small insider sale arising from RSU vesting; amount is immaterial relative to shares outstanding.
The proposed sale of 5,717 shares stems from RSU vesting on 08/29/2025 and will be executed via Morgan Stanley Smith Barney on 09/02/2025. With 101,212,329 shares outstanding, the shares to be sold represent approximately 0.0056% of the outstanding common stock, indicating the transaction is likely routine compensation monetization rather than a major change in insider ownership. Prior sale on 06/02/2025 of 6,034 shares for $8,075.91 is disclosed, showing prior liquidity events by the same person. No information in the filing indicates undisclosed material developments at the company.
TL;DR: Filing appears to meet Rule 144 disclosure requirements and includes standard seller representations.
The form provides required details: class of security, broker, number of shares, aggregate value, acquisition method (vesting of RSUs), and prior sales in the past three months. The notice contains the seller's representation regarding absence of undisclosed material adverse information. The filing does not state a 10b5-1 plan adoption date or other trading-plan details, so no affirmative claim of a pre-arranged trading plan is evident in the form content.
FAQ
What does Alector's (ALEC) Form 144 report?
What broker will execute the sale?
What representation does the seller make about material information?